Literature DB >> 10632706

A transglycosylating 1,3(4)-beta-glucanase from rhodothermus marinus NMR analysis of enzyme reactions.

B O Petersen1, M Krah, J O Duus, K K Thomsen.   

Abstract

The enzymatic hydrolysis of polysaccharides by the 1, 3(4)-beta-glucanase (LamR) from Rhodothermus marinus has been explored. The enzyme cleaves the 1,3-beta-linkages of 3-O-substituted glucose units in 1,3-beta-glucans such as laminarin and curdlan, and also the 1,4-beta-linkages of 3-O-substituted beta-glucose in beta-glucans such as lichenin and 1,3-1, 4-beta-glucan from the cell walls of barley endosperm. The polysaccharide substrates (laminarin, curdlan and barley beta-glucan) were characterised using NMR spectroscopy. The reaction of LamR with its substrates was followed by recording one-dimensional and two-dimensional 1H-NMR and 13C-NMR spectra at suitable time intervals after addition of the enzyme. It is shown that hydrolysis occurs with retention of the anomeric configuration and that LamR performs transglycosylation to generate both 1, 3-beta-glycosidic and 1,4-beta glycosidic linkages. The transglycosylation results in, e.g. formation of the trisaccharide 4-O-glucosyl-laminaribiose from exclusively 1,3-beta-oligoglucosides. When barley 1,3-1,4-beta-glucan was incubated with LamR the beta-1, 4-linkages of 3-O-substituted beta-glycosyl residues were rapidly hydrolysed. Simultaneously de novo formation of 1,3-beta-glycosidic linkages was observed which, however, were cleaved during prolonged incubations. It is shown that a laminaribiosyl unit is the minimum requirement for formation of an enzyme-substrate complex and subsequent hydrolysis/transglycosylation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10632706     DOI: 10.1046/j.1432-1327.2000.01008.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

1.  Real-time NMR monitoring of intermediates and labile products of the bifunctional enzyme UDP-apiose/UDP-xylose synthase.

Authors:  Paul Guyett; John Glushka; Xiaogang Gu; Maor Bar-Peled
Journal:  Carbohydr Res       Date:  2009-03-27       Impact factor: 2.104

2.  Hydrolase and glycosynthase activity of endo-1,3-beta-glucanase from the thermophile Pyrococcus furiosus.

Authors:  J van Lieshout; M Faijes; J Nieto; J van der Oost; A Planas
Journal:  Archaea       Date:  2004-10       Impact factor: 3.273

Review 3.  Rhodothermus marinus: physiology and molecular biology.

Authors:  Snaedis H Bjornsdottir; Thorarinn Blondal; Gudmundur O Hreggvidsson; Gudmundur Eggertsson; Solveig Petursdottir; Sigridur Hjorleifsdottir; Sigridur H Thorbjarnardottir; Jakob K Kristjansson
Journal:  Extremophiles       Date:  2005-08-02       Impact factor: 2.395

4.  Transferase and hydrolytic activities of the laminarinase from Rhodothermus marinus and its M133A, M133C, and M133W mutants.

Authors:  Kirill N Neustroev; Alexander M Golubev; Michael L Sinnott; Rainer Borriss; Martin Krah; Harry Brumer; Elena V Eneyskaya; Sergey Shishlyannikov; Konstantin A Shabalin; Viacheslav T Peshechonov; Vladimir G Korolev; Anna A Kulminskaya
Journal:  Glycoconj J       Date:  2006-11       Impact factor: 3.009

5.  A novel glyco-conjugate vaccine against fungal pathogens.

Authors:  Antonella Torosantucci; Carla Bromuro; Paola Chiani; Flavia De Bernardis; Francesco Berti; Chiara Galli; Francesco Norelli; Cinzia Bellucci; Luciano Polonelli; Paolo Costantino; Rino Rappuoli; Antonio Cassone
Journal:  J Exp Med       Date:  2005-09-05       Impact factor: 14.307

6.  Laser-facilitated epicutaneous immunotherapy with hypoallergenic beta-glucan neoglycoconjugates suppresses lung inflammation and avoids local side effects in a mouse model of allergic asthma.

Authors:  Evgeniia Korotchenko; Viktoria Schießl; Sandra Scheiblhofer; Mario Schubert; Elfriede Dall; Isabella A Joubert; Helen Strandt; Theresa Neuper; Muamera Sarajlic; Renate Bauer; Mark Geppert; David Joedicke; Sabrina Wildner; Susanne Schaller; Stephan Winkler; Gabriele Gadermaier; Jutta Horejs-Hoeck; Richard Weiss
Journal:  Allergy       Date:  2020-07-16       Impact factor: 13.146

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.